Medicare Enrolled

Dr. Shaifali Dugar, M.D.

Rheumatology · Rego Park, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
85-49 ELIOT AVENUE, Rego Park, NY 11374
7184242663
In practice since 2010 (16 years)
NPI: 1528385739 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dugar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dugar? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dugar

Dr. Shaifali Dugar is a rheumatology specialist in Rego Park, NY, with 16 years of NPI registration. Based on federal Medicare data, Dr. Dugar performed 2,963 Medicare services across 557 unique beneficiaries.

Between the years covered by Open Payments, Dr. Dugar received a total of $11,653 from 34 pharmaceutical and/or device companies across 661 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dugar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ Top 31% volume in NY $11,653 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,963
Medicare services
Top 31% in NY for rheumatology
557
Unique beneficiaries
$37
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~185 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 2,042 $18 $83
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
311 $114 $308
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
154 $82 $232
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
108 $1 $14
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
86 $150 $429
X-ray of hand, minimum of 3 views
An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints.
61 $36 $165
Wrist X-ray, minimum 3 views
An imaging test using X-rays to capture at least three different angles of the wrist bones and joints.
59 $40 $173
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
56 $68 $220
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
52 $8 $24
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
22 $85 $232
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
12 $107 $298
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$11,653
Total received (2018-2024)
Avg $1,665/year across 7 years
Top 25% in NY for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
661
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,308 (97.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$345 (3.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,018
2023
$2,377
2022
$2,097
2021
$1,351
2020
$519
2019
$2,380
2018
$911

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Mallinckrodt Hospital Products Inc.
$299
Amgen Inc.
$267
Lilly USA, LLC
$265
ABBVIE INC.
$241
Janssen Biotech, Inc.
$223
UCB, Inc.
$143
GlaxoSmithKline, LLC.
$141
SCILEX PHARMACEUTICALS INC.
$72
Boehringer Ingelheim Pharmaceuticals, Inc.
$64
Alexion Pharmaceuticals, Inc.
$62
Novartis Pharmaceuticals Corporation
$58
Sandoz Inc.
$45
AstraZeneca Pharmaceuticals LP
$45
ANI Pharmaceuticals, Inc.
$43
PFIZER INC.
$25
Aurinia Pharma U.S., Inc.
$24
Top 3 companies account for 41.2% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$1,544
Amgen Inc.
$1,459
Janssen Biotech, Inc.
$938
Lilly USA, LLC
$930
UCB, Inc.
$844
AbbVie Inc.
$727
Horizon Therapeutics plc
$673
GlaxoSmithKline, LLC.
$570
ABBVIE INC.
$524
Boehringer Ingelheim Pharmaceuticals, Inc.
$516
Novartis Pharmaceuticals Corporation
$457
Mallinckrodt Hospital Products Inc.
$413
AbbVie, Inc.
$366
AstraZeneca Pharmaceuticals LP
$258
E.R. Squibb & Sons, L.L.C.
$250
Radius Health, Inc.
$166
Celgene Corporation
$160
Horizon Pharma plc
$119
Alexion Pharmaceuticals, Inc.
$83
Mallinckrodt Enterprises LLC
$82
SCILEX PHARMACEUTICALS INC.
$72
Sandoz Inc.
$63
Aurinia Pharma U.S., Inc.
$60
DePuy Synthes Sales Inc.
$56
Regeneron Healthcare Solutions, Inc.
$55
Mallinckrodt LLC
$53
ANI Pharmaceuticals, Inc.
$43
Bioventus LLC
$39
Genentech USA, Inc.
$34
Mylan Institutional Inc.
$28
GENZYME CORPORATION
$24
Oxford Immunotec USA Inc
$22
MEDAC PHARMA, INC.
$13
Hikma Pharmaceuticals USA
$13
Top 3 companies account for 33.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · DUEXIS · Durolane · EVENITY · Enbrel · HUMIRA · HYRIMOZ · Humira · KEVZARA · KEVZARA SARILUMAB INJECTION · KRYSTEXXA · LUPKYNIS · MONOVISC · Mitigare · OFEV · ORENCIA · ORTHOVISC · Otezla · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STRENSIQ · T-SPOT.TB8 · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tymlos · VIMOVO · XELJANZ · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in Rego Park?
Compare rheumatologists in the Rego Park area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
368
Per 100K population
15.8
County median income
$84,961
Nearest hospital
ELMHURST HOSPITAL CENTER
1.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Dugar is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Dugar experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Dugar performed 2,042 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dugar receive payments from pharmaceutical companies?
Yes. Dr. Dugar received a total of $11,653 from 34 companies across 661 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dugar's costs compare to other rheumatologists in Rego Park?
Dr. Dugar's average Medicare payment per service is $37. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dugar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →